How Are Amino Acids Synthesized in the Body?

Discover how essential and non-essential amino acids are synthesized, detailing the metabolic pathways and core biochemical reactions used in the body.

Your body builds roughly half of the twenty standard amino acids on its own, assembling them from leftovers of other metabolic reactions, primarily intermediates of the citric acid cycle and glycolysis. The process relies heavily on shuffling nitrogen groups between molecules, a reaction called transamination, and on pulling free ammonia into the amino acid glutamate, which then serves as a nitrogen donor for building most of the others. The amino acids your cells can manufacture are traditionally called “nonessential,” but that label is more nuanced than it sounds, and the synthesis itself depends on cooperation between multiple organs, the right vitamins, and even the bacteria living in your gut.

Which Amino Acids Your Body Can and Cannot Make

Of the twenty amino acids used to build proteins, nine cannot be produced by human cells at all. These are the essential amino acids: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. Their carbon skeletons simply cannot be assembled from scratch in our cells, so they must come from food. The remaining eleven, including glutamate, alanine, aspartate, and serine, can be synthesized internally, though the body’s ability to produce enough of each one is not guaranteed under every condition.

A strict biochemical analysis narrows the truly dispensable amino acids, the ones the body can always make in sufficient quantities, to just glutamate and serine. On the flip side, only lysine, threonine, and tryptophan are absolutely indispensable with zero capacity for internal synthesis. Everything in between falls into a gray zone of “conditionally essential” amino acids, meaning the body can produce them but sometimes not fast enough, depending on health status, age, and the availability of precursor molecules. Arginine, for example, is made internally but becomes essential for premature infants whose organ systems are not yet mature enough to keep up with demand. Tyrosine can be synthesized from phenylalanine, but if phenylalanine intake is low, you cannot make enough tyrosine either.

The old assumption that all “nonessential” amino acids are always produced in adequate amounts has been questioned. Researchers have pointed out that there has been no strong experimental evidence over the past century to confirm that internal synthesis alone meets the full needs for growth and health in every situation. In practice, a varied diet supplies a mix of both essential and nonessential amino acids, and the body’s own synthesis fills in the gaps rather than carrying the entire load.

Where the Nitrogen Comes From

Every amino acid has an amino group, a cluster of nitrogen and hydrogen, attached to its carbon backbone. Building new amino acids means finding a source of nitrogen and attaching it to a carbon skeleton. In human cells, this process starts with free ammonia ions, which are abundant but toxic at high concentrations. The enzyme glutamine synthetase grabs an ammonia molecule and attaches it to the amino acid glutamate, producing glutamine. Glutamine then circulates through the body as a safe nitrogen shuttle, delivering its nitrogen payload to cells that need it for building other amino acids or for DNA synthesis.

A complementary path runs through an enzyme called glutamate dehydrogenase, which works in mitochondria and can either release ammonia from glutamate or pack ammonia into the carbon skeleton alpha-ketoglutarate to form glutamate. In the brain, this system is especially important: astrocytes use glutamine synthetase to soak up ammonia, and about a quarter of ammonia arriving in blood is captured in a single pass through the brain. When ammonia levels spike, the glutamate dehydrogenase reaction can shift toward making more amino acids from that excess ammonia, essentially turning a toxic waste product into useful building material.

Transamination and the Central Role of Glutamate

Once glutamate has been loaded with nitrogen, the body uses a simple swap called transamination to build other amino acids. In a transamination reaction, an enzyme transfers the amino group from glutamate onto a different carbon skeleton, converting that skeleton into a new amino acid and leaving behind alpha-ketoglutarate (the carbon skeleton glutamate started with). This alpha-ketoglutarate cycles back to pick up another nitrogen, and the process repeats. Vitamin B6 sits at the active site of almost every transaminase enzyme, making it essential for the reaction to work.

Because glutamate is the nitrogen donor in most of these swaps, it acts as the central hub of amino acid production. Nearly every nonessential amino acid traces its nitrogen back to glutamate at some point. Alpha-ketoglutarate, the carbon skeleton left behind after transamination, is itself a citric acid cycle intermediate, which means the body’s energy-producing machinery and its amino acid factory are deeply intertwined.

Building Amino Acids From Citric Acid Cycle and Glycolysis Leftovers

The carbon backbones for nonessential amino acids come from a handful of common metabolic intermediates. Several of the simplest amino acids, including glutamate, aspartate, asparagine, and alanine, are built in just one or two steps from citric acid cycle molecules. Alanine, for instance, is made by transferring an amino group onto pyruvate, the end product of sugar breakdown. Aspartate forms when an amino group is transferred onto oxaloacetate, another citric acid cycle intermediate. Asparagine is then made from aspartate in one additional step.

Serine follows a slightly different route, branching off from an intermediate of glycolysis called 3-phosphoglycerate. A three-step enzyme sequence oxidizes, transaminates, and then dephosphorylates this molecule to yield serine. From serine, the body can make glycine by removing a single carbon unit, and cysteine can be produced using the sulfur from the essential amino acid methionine combined with serine’s carbon backbone. These reactions link amino acid synthesis tightly to the pathways that process glucose for energy, meaning that when energy metabolism is disrupted, amino acid production can be disrupted too.

When One Amino Acid Makes Another

Some nonessential amino acids are not built from scratch but are converted from essential ones. The best-known example is tyrosine, which is produced by adding a hydroxyl group to phenylalanine, a reaction carried out by the enzyme phenylalanine hydroxylase. This conversion was first demonstrated in rats back in 1940, making it one of the earliest amino acid transformations ever identified. In humans, both the liver and the kidneys contribute to this conversion.

This dependency creates a vulnerability. In phenylketonuria (PKU), the enzyme phenylalanine hydroxylase is deficient or absent, so phenylalanine accumulates to toxic levels while tyrosine levels drop. Tyrosine is a precursor to the neurotransmitters dopamine and norepinephrine, which is why untreated PKU can cause severe neurological problems. Beyond impaired neurotransmitter synthesis, current research suggests that the damage in PKU also involves changes to protein synthesis, increased oxidative stress, and disruptions in brain energy metabolism. PKU illustrates a broader principle: when any link in the amino acid synthesis chain breaks, the consequences can cascade far beyond the amino acid itself.

Amino Acid Synthesis Is a Multi-Organ Project

No single organ handles all amino acid synthesis. The liver does a large share of the work, but the gut, kidneys, and skeletal muscle all play distinct roles, and the amino acids or their precursors are shuttled between organs through the bloodstream.

Arginine production is a striking example. The small intestine converts glutamine and proline into citrulline, an intermediate that it releases into the blood. The kidneys then take up that citrulline and convert it into arginine. This gut-to-kidney relay, called the intestinal-renal axis, has been confirmed in mice and neonatal pigs, and is considered the primary route for endogenous arginine production in mammals. In neonatal animals, this axis is already functioning, though its capacity is lower than in adults. Any condition that damages either the gut lining or kidney function can impair arginine production, which matters because arginine is a precursor for nitric oxide, a molecule critical for blood vessel dilation and immune defense.

Skeletal muscle plays a key role in alanine and glutamine production, especially during fasting. Muscle tissue breaks down branched-chain amino acids (valine, leucine, isoleucine) and uses their nitrogen to build glutamate. Glutamate then donates its nitrogen to pyruvate to form alanine, or picks up an extra ammonia to become glutamine. Alanine travels from muscle to the liver, where the liver strips off the amino group, uses the carbon skeleton to make new glucose, and sends that glucose back to the muscles for fuel. This loop, known as the glucose-alanine cycle, becomes rate-controlling for the liver’s glucose production during prolonged fasting.

Your Gut Bacteria Pitch In

The trillions of bacteria in your intestines are not just passengers. They synthesize amino acids for their own needs, and some of that production leaks into your system. Gut microbes can make all twenty standard amino acids, including the nine essential ones that human cells cannot produce.

Quantifying this contribution is tricky, but isotope-labeling studies have estimated that between 1 and 20 percent of circulating plasma lysine, for instance, comes from microbial sources in adults eating an adequate diet. That corresponds to a gross microbial lysine contribution of roughly 11 to 68 milligrams per kilogram of body weight per day. Lysine is one of the essential amino acids that human cells cannot make at all, so even a modest microbial contribution is interesting. However, most of the amino acids bacteria produce are absorbed in the large intestine, where amino acid uptake is less efficient than in the small intestine, so the practical nutritional impact is still debated.

How Cells Know When to Stop Making Amino Acids

Amino acid synthesis does not run at a fixed rate. Cells adjust production based on how much of each amino acid is already present, using a self-limiting mechanism called feedback inhibition. When levels of a particular amino acid rise high enough, that amino acid binds to a regulatory site on the first enzyme in its own biosynthetic pathway, changing the enzyme’s shape so it works more slowly or shuts off entirely. At least sixteen amino acids regulate their own production this way.

Research in bacteria has shown that this feedback system does more than just prevent overproduction. When feedback inhibition was experimentally removed from seven amino acid pathways, cells responded by actually lowering the amounts of the biosynthetic enzymes they made. Despite having less enzyme, the cells still produced enough amino acid, revealing that cells normally carry more biosynthetic enzyme than they strictly need. This built-in surplus acts as a buffer, making amino acid production robust against random fluctuations in gene expression. While these particular experiments were done in bacteria, feedback inhibition of amino acid synthesis is a universal feature of cellular life, and mammalian cells use analogous regulatory mechanisms.

At a larger scale, amino acid levels also feed into the mTORC1 signaling pathway, a master switch for cell growth. When amino acid levels are high, mTORC1 promotes protein building and cell division. When levels drop, mTORC1 activity falls, slowing growth and triggering recycling of existing proteins through autophagy. This creates a layered control system: individual pathways self-regulate through feedback inhibition, while the cell’s overall growth program adjusts to the total amino acid supply via mTORC1.

Why We Lost the Ability to Make Nine of Them

Humans did not always lack the ability to synthesize all twenty amino acids. Ancient single-celled organisms could make every one. As organisms evolved the ability to eat other organisms, the selective pressure to maintain all those biosynthetic pathways relaxed. If you reliably get an amino acid from food, there is no survival cost to losing the genes that produce it, and losing them actually saves energy and cellular resources.

Genomic analysis has shown that the same nine amino acid pathways were lost independently in multiple lineages: animals, the social amoeba Dictyostelium, and several parasitic protists including Leishmania, Plasmodium (the malaria parasite), and Cryptosporidium. The fact that these very different organisms lost the same nine pathways suggests something about those particular synthesis routes: they tend to be long, enzyme-heavy, and energetically costly, making them the first to become dispensable when dietary sources are available. The pathways for glutamate, aspartate, and alanine, by contrast, are short and tightly connected to core energy metabolism, which is probably why every animal lineage has held onto them.

Selenocysteine, the 21st Amino Acid

Beyond the standard twenty, human cells make a rare amino acid called selenocysteine, sometimes called the 21st amino acid. Its synthesis is unlike any other amino acid in the body: it is built directly on its transfer RNA rather than being made as a free molecule and then attached. The process starts with serine being loaded onto a special tRNA, then phosphorylated, and finally converted to selenocysteine using a selenium-containing donor molecule called selenophosphate. Selenocysteine was the last protein amino acid in eukaryotes whose biosynthetic pathway was fully worked out.

Only about 25 human proteins contain selenocysteine, but several of them are critical antioxidant enzymes (the glutathione peroxidases and thioredoxin reductases). Because selenium is required to build selenocysteine, adequate dietary selenium is necessary for these enzymes to function. This makes selenocysteine synthesis dependent on a trace mineral rather than on the typical amino acid or citric acid cycle precursors that feed production of the standard twenty.

Amino Acid Production Follows a Daily Clock

Amino acid synthesis does not hum along at a constant rate throughout the day. Research on liver metabolism has found that circadian rhythms exert a strong influence over the production of amino acids, carbohydrates, and lipids. Many metabolites involved in amino acid and nitrogen metabolism cycle with peaks and troughs that align with the body’s internal clock, not just with meal timing. One-carbon metabolism, methylation reactions, and nitrogen-handling pathways all show rhythmic oscillations, with most of these metabolites peaking together but a few key intermediates peaking at the opposite phase of the cycle.

This matters practically because it means your body’s capacity to process and build amino acids shifts over the course of a day. Disrupting circadian rhythms through shift work, chronic jet lag, or erratic eating patterns could, in theory, impair the coordination of these metabolic cycles. Research on high-fat diets has shown that dietary stress can amplify or distort these oscillations, suggesting that the interplay between what you eat and when you eat it affects amino acid metabolism in ways we are only beginning to map out.